Benfotiamine

Description

Benfotiamine is a derivative of vitamin B1. It is used for the treatment and prevention of vitamin B1 deficiency that cannot be corrected through dietary modifications. It may also be used for the treatment of neuropathies and cardiovascular disorders caused due to vitamin B1 deficiency. It may also be used for the treatment of Beriberi and Wernicke's encephalopathy.

Side effects

Major & minor side effects for Benfotiamine

  • Cough
  • Difficulty in swallowing
  • Itching and skin rash
  • Swelling of face, lips, eyelids, or tongue
  • Difficulty in breathing
  • Nausea
  • Weight gain

Uses of Benfotiamine

What is it prescribed for?

  • Beriberi
  • Dietary Deficiency
  • Wernicke Encephalopathy
  • Neuropathy
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time required by this medicine to show its action is not clinically established.
  • Duration of effect
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit-forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to benfotiamine, thiamine, or any other inactive ingredients present in the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Other medicines

This medicine may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you report all your current medicines, including any herbs and supplements, to the doctor before beginning treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for the next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine as instructed by your doctor. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine breaks down dietary sugars and corrects the nerve and heart problems caused due to vitamin B1 deficiency.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Vitamins

Schedule

OTC

Benfotiamine [Internet]. Pubchem.ncbi.nlm.nih.gov. 2018 [cited 14 September 2018]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/benfotiamine#section=Top

Benfotiamine - DrugBank [Internet]. Drugbank.ca. 2018 [cited 14 September 2018]. Available from:

https://www.drugbank.ca/drugs/DB11748

Co.KG W. Product [Internet]. Wörwag Pharma DE. 2018 [cited 14 September 2018]. Available from:

https://www.woerwagpharma.de/en/products/product/milgamma-protekt/

Haupt E e. Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study). - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2018 [cited 14 September 2018]. Available from:

https://www.ncbi.nlm.nih.gov/pubmed/15726875

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now
Something doesn’t feel right?
Report an error

Information on this page was last updated on 19 Sep 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.